These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22509084)

  • 1. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
    Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
    Hsu YC; Liou JM; Yang TH; Hsu WL; Lin HJ; Wu HT; Lin JT; Wang HP; Wu MS
    J Gastroenterol; 2011 Feb; 46(2):183-90. PubMed ID: 20957498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
    Iwakiri R; Tominaga K; Furuta K; Inamori M; Furuta T; Masuyama H; Kanke K; Nagahara A; Haruma K; Kinoshita Y; Higuchi K; Takahashi S; Kusano M; Iwakiri K; Kato M; Hongo M; Hiraishi H; Watanabe S; Miwa H; Naito Y; Fujimoto K; Arakawa T
    Aliment Pharmacol Ther; 2013 Oct; 38(7):729-40. PubMed ID: 23957383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
    Otaka M; Jin M; Odashima M; Matsuhashi T; Wada I; Horikawa Y; Komatsu K; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():42-6. PubMed ID: 15943846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Helicobacter pylori eradication on patients with functional dyspepsia].
    de Artaza Varasa T; Valle Muñoz J; Pérez-Grueso MJ; García Vela A; Martín Escobedo R; Rodríguez Merlo R; Cuena Boy R; Carrobles Jiménez JM
    Rev Esp Enferm Dig; 2008 Sep; 100(9):532-9. PubMed ID: 19025303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
    Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).
    Sakurai K; Nagahara A; Inoue K; Akiyama J; Mabe K; Suzuki J; Habu Y; Araki A; Suzuki T; Satoh K; Nagami H; Harada R; Tano N; Kusaka M; Fujioka Y; Fujimura T; Shigeto N; Oumi T; Miwa J; Miwa H; Fujimoto K; Kinoshita Y; Haruma K
    BMC Gastroenterol; 2012 May; 12():42. PubMed ID: 22548767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia.
    Maity S; Choudhury S; Hazra A; Das AK
    Indian J Pharmacol; 2014; 46(5):498-502. PubMed ID: 25298578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC; Hartog GD; Mulder CJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
    Smith T; Verzola E; Mertz H
    Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies.
    Seno H; Nakase H; Chiba T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: current treatment options and management of functional dyspepsia.
    Lacy BE; Talley NJ; Locke GR; Bouras EP; DiBaise JK; El-Serag HB; Abraham BP; Howden CW; Moayyedi P; Prather C
    Aliment Pharmacol Ther; 2012 Jul; 36(1):3-15. PubMed ID: 22591037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
    Ang TL; Fock KM; Teo EK; Chan YH; Ng TM; Chua TS; Tan JY
    J Gastroenterol; 2006 Jul; 41(7):647-53. PubMed ID: 16933001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabeto plus: a valuable drug for managing functional dyspepsia.
    Ghosh A; Halder S; Mandal S; Mandal A; Basu M; Dabholkar P
    J Indian Med Assoc; 2008 Nov; 106(11):752-4. PubMed ID: 19368103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.